BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26752302)

  • 1. A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus.
    McCarthy SD; Majchrzak-Kita B; Racine T; Kozlowski HN; Baker DP; Hoenen T; Kobinger GP; Fish EN; Branch DR
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004364. PubMed ID: 26752302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
    Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X
    PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of
    Goyal S; Binnington B; McCarthy SDS; Desmaële D; Férrié L; Figadère B; Loiseau PM; Branch DR
    F1000Res; 2020; 9():268. PubMed ID: 32528661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
    Cong Y; Dyall J; Hart BJ; DeWald LE; Johnson JC; Postnikova E; Zhou H; Gross R; Rojas O; Alexander I; Josleyn N; Zhang T; Michelotti J; Janosko K; Glass PJ; Flint M; McMullan LK; Spiropoulou CF; Mierzwa T; Guha R; Shinn P; Michael S; Klumpp-Thomas C; McKnight C; Thomas C; Eakin AE; O'Loughlin KG; Green CE; Catz P; Mirsalis JC; Honko AN; Olinger GG; Bennett RS; Holbrook MR; Hensley LE; Jahrling PB
    PLoS One; 2016; 11(11):e0166318. PubMed ID: 27902714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based Assays.
    Dyall J; Hart BJ; Postnikova E; Cong Y; Zhou H; Gerhardt DM; Freeburger D; Michelotti J; Honko AN; DeWald LE; Bennett RS; Olinger GG; Jahrling PB; Hensley LE
    J Infect Dis; 2017 May; 215(9):1416-1420. PubMed ID: 28368541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.
    Luthra P; Aguirre S; Yen BC; Pietzsch CA; Sanchez-Aparicio MT; Tigabu B; Morlock LK; García-Sastre A; Leung DW; Williams NS; Fernandez-Sesma A; Bukreyev A; Basler CF
    mBio; 2017 Apr; 8(2):. PubMed ID: 28377530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J
    Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
    Hartman AL; Dover JE; Towner JS; Nichol ST
    J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
    Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
    Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.
    Zhu Y; Curtis M; Qi X; Miller MD; Borroto-Esoda K
    Antivir Chem Chemother; 2009; 19(4):165-76. PubMed ID: 19374144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ Inhibits Ebola Virus Infection.
    Rhein BA; Powers LS; Rogers K; Anantpadma M; Singh BK; Sakurai Y; Bair T; Miller-Hunt C; Sinn P; Davey RA; Monick MM; Maury W
    PLoS Pathog; 2015; 11(11):e1005263. PubMed ID: 26562011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic drug combination effectively blocks Ebola virus infection.
    Sun W; He S; Martínez-Romero C; Kouznetsova J; Tawa G; Xu M; Shinn P; Fisher E; Long Y; Motabar O; Yang S; Sanderson PE; Williamson PR; García-Sastre A; Qiu X; Zheng W
    Antiviral Res; 2017 Jan; 137():165-172. PubMed ID: 27890675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
    PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
    Subramanian GM; Moore PA; Gowen BB; Olsen AL; Barnard DL; Paragas J; Hogan RJ; Sidwell RW
    Chemotherapy; 2008; 54(3):176-80. PubMed ID: 18560223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication.
    Luthra P; Liang J; Pietzsch CA; Khadka S; Edwards MR; Wei S; De S; Posner B; Bukreyev A; Ready JM; Basler CF
    Antiviral Res; 2018 Feb; 150():193-201. PubMed ID: 29294299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of protection against ebola virus from chloroquine in mice and hamsters.
    Falzarano D; Safronetz D; Prescott J; Marzi A; Feldmann F; Feldmann H
    Emerg Infect Dis; 2015 Jun; 21(6):1065-7. PubMed ID: 25988934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
    Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J
    Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
    Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.